Related Experiment Videos
Lymphangiogenesis in human gynaecological cancers.
Philippe O Van Trappen1, Michael S Pepper
1Gynaecological Cancer Centre and Cancer Research UK Translational Oncology Laboratory, Queen Mary University of London, St Bartholomew's Hospital, London, UK.
Angiogenesis
|October 8, 2005
Summary
Tumor-associated lymphatics facilitate cancer metastasis. Vascular Endothelial Growth Factor-C (VEGF-C) and VEGF-D promote lymphangiogenesis, aiding tumor cell spread to lymph nodes, especially in gynecological cancers.
Area of Science:
- Oncology
- Cancer Biology
- Molecular Medicine
Background:
- Metastasis, the spread of tumor cells, causes most cancer deaths.
- Tumor-associated lymphatics are implicated in cancer cell dissemination.
- Lymphangiogenesis, the formation of new lymphatic vessels, is a key process.
Purpose of the Study:
- To review lymphangiogenesis mechanisms in metastatic tumor spread.
- To examine the role of VEGF-C and VEGF-D in gynecological cancer metastasis.
- To discuss potential anti-lymphangiogenic strategies.
Main Methods:
- Review of existing clinical and experimental findings.
- Analysis of the correlation between VEGF-C/VEGF-D expression and tumor cell dissemination.
- Focus on gynecological cancer models.
Main Results:
- Increased expression of VEGF-C and VEGF-D in primary tumors correlates with tumor cell spread to lymph nodes.
- Lymphangiogenesis, driven by VEGF-C and VEGF-D, is a critical pathway for metastasis.
- These factors play a significant role in gynecological cancers.
Conclusions:
- Tumor-associated lymphatics and lymphangiogenesis are crucial for cancer metastasis.
- VEGF-C and VEGF-D are key drivers of this process, particularly in gynecological cancers.
- Targeting lymphangiogenesis presents a potential therapeutic strategy.